Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

Clinical trial NCT06008405 · UNKNOWN

Trial details

NCT number: NCT06008405
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2023-09-01
Primary completion: 2025-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.